Clinical Trials Directory

Trials / Completed

CompletedNCT02194192

Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section

Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section; a Randomized, Double Blinded, Placebo Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Maternal hypotension after spinal anesthesia in parturients undergoing cesarean section is a very common problem leading to several complications to both patients and their babies. It can cause maternal discomfort, lightheadedness, nausea and vomiting. The most important complication is the decreasing blood flow to babies; which may lead to fetal acidosis. Many interventions has been studied in order to prevent hypotension after spinal anesthesia in cesarean section e.g., fluid loading: colloid vs crystalloid, medications: ephedrine, phenylephrine, and metaraminol, etc. The recent study showed ondansetron (the antiemetic drug) can be effectively used to prevent hypotension after spinal anesthesia in normal patients or parturients. The action of ondansetron is believed to inhibit Bezold-Jarish reflex. This aim of this study is to compare the efficacy of ephedrine and ondansetron in the prevention of maternal hypotension after spinal anesthesia in cesarean section.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboNormal saline 10 ml
DRUGOndansetronOndasetron 8 mg IV after spinal anesthesia
DRUGEphedrineEphedrine 10 mg IV after spinal anesthesia

Timeline

Start date
2014-07-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-07-18
Last updated
2015-03-17

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02194192. Inclusion in this directory is not an endorsement.